BAM
ANGO icon

Bastion Asset Management’s AngioDynamics ANGO Stock Holding History

Bastion Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Sell
923,270
-389,732
-30% -$4.44M 3.66% 7
2026
Q1 		$14.1M Buy
1,313,002
+194,822
+17% +$2.11M 4.3% 3
2025
Q4 		$12.9M Sell
1,118,180
-145,823
-12% -$1.8M 7.11% 2
2025
Q3 		$13.4M Buy
1,264,003
+304,960
+32% +$2.94M 7.74% 1
2025
Q2 		$9.81M Buy
959,043
+304,217
+46% +$2.98M 4.6% 3
2025
Q1 		$6.6M Buy
+654,826
New +$6.88M 3.56% 4

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bastion Asset Management's ANGO Position: Q2 2026 in Review

Bastion Asset Management reduced its AngioDynamics (ANGO) stake by 30% in Q2 2026, selling an estimated $4.44M and leaving 923,270 shares worth $10.8M. The position accounts for 3.66% of the portfolio, ranked #7.

Bastion Asset Management first reported a position in ANGO in Q1 2025 and has held it in 6 quarters since. The position peaked at $14.1M in Q1 2026. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Bastion Asset Management held 923,270 shares of AngioDynamics worth $10.8M as of Q2 2026.
  • Bastion Asset Management sold 389,732 AngioDynamics shares in Q2 2026, an estimated $4.44M.
  • AngioDynamics made up 3.66% of Bastion Asset Management's portfolio in Q2 2026, its #7 holding.
  • Bastion Asset Management first reported a position in AngioDynamics in Q1 2025 and has held it in 6 quarters since.
  • Bastion Asset Management's AngioDynamics position peaked at $14.1M in Q1 2026.
  • 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Bastion Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.